Health Catalyst, Inc.

HCAT

US42225T1079

Software

Market Closed - Nasdaq Other stock markets 01:30:00 23/05/2024 am IST			5-day change	1st Jan Change
6.85 ^USD	+1.18%		+1.03%	-26.03%

10/05	Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating	MT
09/05	Health Catalyst Seeks M&A	CI

Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024

May 10, 2024 at 01:33 am IST

Health Catalyst, Inc. announced impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported impairment of long-lived assets of $2,200,000.

Latest news about Health Catalyst, Inc.

Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating	10/05	MT
Health Catalyst Seeks M&A	10/05	CI
Health Catalyst, Inc. Provides Revenue Guidance for the Second Quarter and Reiterates Revenue Guidance for the Full Year of 2024	10/05	CI
Transcript : Health Catalyst, Inc., Q1 2024 Earnings Call, May 09, 2024	10/05
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 Revenue $74.7M, vs. Street Est of $74.8M	10/05	MT
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 EPS $0.05, vs. Street Est of $0.03	10/05	MT
Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024	10/05	CI
North American Morning Briefing : Stock Futures -2-	11/04	DJ
KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets	10/04	MT
North American Morning Briefing : Traders Await -2-	10/04	DJ
Transcript : Health Catalyst, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:15 AM	14/03
Health Catalyst Shares Rise After CEO Stock Purchase	28/02	MT
Transcript : Health Catalyst, Inc. - Special Call	27/02
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating	26/02	MT
Evercore ISI Adjusts Price Target on Health Catalyst to $10 From $11, Maintains Outperform Rating	23/02	MT
Canaccord Genuity Trims Price Target on Health Catalyst to $11 From $12, Maintains Buy Rating	23/02	MT
Transcript : Health Catalyst, Inc., Q4 2023 Earnings Call, Feb 22, 2024	23/02
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 EPS $0.02, vs. Street Est of $-0.01	23/02	MT
Health Catalyst, Inc. Announces CFO Changes, Effective March 1, 2024	23/02	CI
Health Catalyst, Inc. Announces Board Changes, Effective March 1, 2024	23/02	CI
Health Catalyst, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02	CI
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 Revenue $75.1M, vs. Street Est of $73.6M	23/02	MT
Health Catalyst, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024	23/02	CI
Health Catalyst, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	23/02	CI
North American Morning Briefing : Cautious Start -2-	29/01	DJ

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Companyâs solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.

Sector

Software

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Health Catalyst, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.85 USD

Average target price

11.5 USD

Spread / Average Target

+67.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Application Software

	1st Jan change	Capi.
HEALTH CATALYST, INC.	-26.03%	40Cr
ADOBE INC.	-18.89%	22TCr
WORKDAY INC.	-5.86%	6.89TCr
ROPER TECHNOLOGIES, INC.	+0.42%	5.86TCr
AUTODESK, INC.	-9.66%	4.71TCr
DATADOG, INC.	+1.13%	4.11TCr
ELECTRONIC ARTS INC.	-1.22%	3.61TCr
ANSYS, INC.	-10.06%	2.85TCr
APPLOVIN CORPORATION	+100.75%	2.63TCr
PTC INC.	+5.03%	2.2TCr

Application Software